medRxiv
Worth it
Confidence: Medium
Free and field-standard for health researchers sharing unreviewed findings before journal publication.
New check
Comparison
medRxiv and Biorxiv both land on Worth it.
Free and field-standard for health researchers sharing unreviewed findings before journal publication.
If you're a life-scientist, post here: it's free, citable, donor-funded, and the field standard for sharing early.
| Compare | medRxiv | Biorxiv |
|---|---|---|
| Verdict | Worth it | Worth it |
| Best for | Clinical and public-health researchers | Biology researchers sharing results early |
| Who it's not for | Patients seeking medical advice | Anyone expecting peer-reviewed, validated findings |
| Privacy | No known public vulnerabilities found in the sources reviewed. | No known breaches; one disclosed XSS on the submission subdomain and brief Cloudflare-related downtime. |
| Support quality | No evidence in sources. | No support evidence in sources |
| Public sentiment | Researchers treat medRxiv as the go-to venue for early clinical findings, while clinicians and readers debate how much preprint results can be trusted.⁷ | Researchers on Reddit and ResearchGate report mostly positive preprint experiences, with scooping risk the recurring worry. |
| Biggest gotcha | Preprints here are not peer-reviewed . never treat them as final evidence.⁶ | Scooping risk: your unpublished findings go public before journal acceptance |